05/07/2024
4:28 PM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2024
12:07 PM | Soleno Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13D/A | |
05/01/2024
12:10 PM | Soleno Therapeutics (Issuer)
Vivo Opportunity Fund Holdings, L.P. (Reporting)
Vivo Opportunity, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
4:53 PM | Huang Michael F. (Reporting)
Soleno Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/30/2024
4:54 PM | Manning Meredith (Reporting)
Soleno Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/22/2024
4:06 PM | Soleno Therapeutics (Filer)
| Form ARS | |
04/22/2024
3:31 PM | Soleno Therapeutics (Filer)
| Form DEF 14A | |
|
04/22/2024
3:15 PM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/03/2024
8:36 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
8:37 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
8:39 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
8:40 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
5:06 AM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
4:35 PM | JANUS HENDERSON GROUP PLC (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13G/A | |
02/07/2024
7:01 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13G/A | |
01/30/2024
3:57 PM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2024
4:42 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
4:44 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
4:47 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
3:31 PM | MARIO ERNEST (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:34 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:35 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:36 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:37 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:16 PM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2023
5:00 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
6:57 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
4:09 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023
8:32 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
8:32 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
8:34 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
8:34 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
3:46 PM | Soleno Therapeutics (Subject)
Yen Kristen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023
3:53 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023
5:17 PM | Soleno Therapeutics (Subject)
Yen Kristen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2023
6:05 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2023
6:21 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2023
7:41 PM | MARIO ERNEST (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
7:02 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
7:03 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
7:04 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Proof that the Musk/Bezos rivalry is about to hit a new level (Ad) Elon Musk Humiliated
Since Jeff Bezos and Elon Musk first met in 2004 — they've been involved in a bitter feud… from rockets, to electric vehicles to who's the world richest person…for going on two decades these two have been at each others throats… Go here now for full story. |
12/04/2023
7:06 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
8:50 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
8:51 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
8:52 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
8:52 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
11:15 PM | Soleno Therapeutics (Filer)
| Form EFFECT | |
10/23/2023
3:20 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13D/A | |
10/20/2023
3:32 PM | Soleno Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/16/2023
3:30 PM | Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13D/A | |
10/12/2023
3:30 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13G | |
10/12/2023
3:05 PM | COMMODORE CAPITAL LP (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13G | |
10/11/2023
3:30 PM | Soleno Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13D/A | |
10/10/2023
3:30 PM | Fairmount Funds Management LLC (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13G | |
10/06/2023
10:45 AM | JANUS HENDERSON GROUP PLC (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13G | |
10/05/2023
4:09 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13G | |
10/04/2023
3:30 PM | Soleno Therapeutics (Issuer)
Vivo Opportunity Fund Holdings, L.P. (Reporting)
Vivo Opportunity, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2023
9:36 AM | Soleno Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
10/02/2023
6:54 PM | Abingworth Bioventures VII LP (Reporting)
Abingworth LLP (Reporting)
Carlyle Genesis UK LLC (Reporting)
Carlyle Group Inc. (Reporting)
Carlyle Group Inc. (Reporting)
Carlyle Holdings I GP Inc. (Reporting)
Carlyle Holdings I GP Sub L.L.C. (Reporting)
Carlyle Holdings I L.P. (Reporting)
Carlyle Investment Management LLC (Reporting)
CG Subsidiary Holdings L.L.C. (Reporting)
Soleno Therapeutics (Issuer)
TC Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/29/2023
3:51 PM | Soleno Therapeutics (Filer)
| Form 424B5 | |
09/28/2023
8:51 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13D/A | |
09/28/2023
4:00 PM | Soleno Therapeutics (Issuer)
Vivo Opportunity Fund Holdings, L.P. (Reporting)
Vivo Opportunity, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/28/2023
2:45 PM | EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/28/2023
6:00 AM | Soleno Therapeutics (Subject)
| Form FWP | |
09/28/2023
6:02 AM | Soleno Therapeutics (Subject)
| Form FWP | |
09/27/2023
8:32 PM | Soleno Therapeutics (Filer)
| Form S-3MEF | |
09/27/2023
4:23 PM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2023
4:26 PM | Soleno Therapeutics (Filer)
| Form 424B5 | |
09/26/2023
6:30 AM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/18/2023
3:15 PM | Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13D/A | |
08/16/2023
3:12 PM | Pauls Matthew (Reporting)
Soleno Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/16/2023
3:13 PM | Pauls Matthew (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2023
8:00 AM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2023
4:25 PM | Soleno Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/02/2023
11:15 PM | Soleno Therapeutics (Filer)
| Form EFFECT | |
07/21/2023
3:10 PM | Soleno Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
07/10/2023
3:06 PM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2023
7:13 PM | Soleno Therapeutics (Issuer)
Volck Birgitte (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2023
4:41 PM | EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2023
4:00 PM | Soleno Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13D | |
05/30/2023
3:15 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13D/A | |
05/26/2023
5:26 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
5:27 PM | Harris William G (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
5:28 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
5:28 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
5:29 PM | MARIO ERNEST (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
5:30 PM | Melincoff Gwen A (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
5:30 PM | Sinclair Andrew (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
5:39 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
4:57 PM | EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
12:14 PM | SCHULER JACK W (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13D/A | |
Gold Set to EXPLODE! (Ad) Gold has already reached all-time highs, and experts believe it's not slowing down any time soon.
In fact, some analysts predict a $7,000 price tag by 2025. Click here now to download the free Precious Metals Buying Guide! |
05/23/2023
5:47 PM | EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/18/2023
3:31 PM | EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Soleno Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/18/2023
3:32 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13D | |
05/15/2023
3:04 PM | SCHULER JACK W (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2023
4:28 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2023
4:28 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2023
3:30 PM | Abingworth LLP (Reporting)
Carlyle Genesis UK LLC (Reporting)
Carlyle Group Inc. (Reporting)
Carlyle Group Inc. (Reporting)
Carlyle Holdings I GP Inc. (Reporting)
Carlyle Holdings I GP Sub L.L.C. (Reporting)
Carlyle Holdings I L.P. (Reporting)
Carlyle Investment Management LLC (Reporting)
CG Subsidiary Holdings L.L.C. (Reporting)
Soleno Therapeutics (Issuer)
TC Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2023
3:32 PM | Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13D/A | |
